European Biotech Targeting Anti-ageing: Novel mitophagy inducers and gene therapies that restore cellular function and decelerate the ageing process.

GENE therapy; BIOTECHNOLOGY; BIOLOGICAL models; AUTOPHAGY; GERIATRICS; CELL physiology; BIOLOGICAL products; NEURODEGENERATION; HEALTH planning

The article highlights the growing focus on ageing as a druggable condition, with advances in understanding mitochondrial dysfunction, inflammation, and cellular senescence driving pharmaceutical innovation. FDA-approved drugs like rapamycin and metformin have shown potential in slowing ageing, while companies like Aeovian Pharmaceuticals are developing next-generation inhibitors for age-related diseases.